期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Medicine and Data. 2024; 8: (3) ; 83-86 ; DOI: 10.12208/j.ijmd.20240044.

Clinical study of Leizumab injection combined with cataract phacoemulsification in the treatment of cataract complicated with diabetic macular edema
雷珠单抗注射液联合白内障超声乳化治疗白内障合并糖尿病性黄斑水肿的临床研究

作者: 周翠平 *

江苏省响水县人民医院眼科 江苏响水

*通讯作者: 周翠平,单位:江苏省响水县人民医院眼科 江苏响水;

发布时间: 2024-10-28 总浏览量: 69

摘要

目的 探究分析雷珠单抗注射液联合白内障超声乳化治疗白内障合并糖尿病性黄斑水肿的临床效果。方法 时间:2023年1月至2023年12月,对象:白内障合并糖尿病性黄斑水肿患者共40例,分组:随机分为对照组与观察组。对照组白内障超声乳化治疗,观察组采用雷珠单抗注射液联合白内障超声乳化治疗,对比两组最佳矫正视力,黄斑中心视网膜厚度;眼压水平以及并发症发生率。结果 观察组优于对照组,P<0.05。结论 雷珠单抗注射液联合白内障超声乳化可显著改善患者最佳矫正视力,黄斑中心视网膜厚度;眼压水平,且具有优良的安全性,值得推广与应用。

关键词: 白内障;糖尿病性黄斑水肿;雷珠单抗;白内障超声乳化;最佳矫正视力,黄斑中心视网膜厚度;眼压水平;并发症发生率

Abstract

Objective To explore the clinical effect of lezumab injection combined with phacoemulsification in cataract combined with diabetic macular edema.
Methods time: January 2023 to December 2023, target: 40 patients with cataract and diabetic macular edema, group: randomized into control group and observation group. The control group received cataract phacoemulsification, and the observation group used rizumab injection combined with cataract phacoemulsification, comparing the two groups with best corrected visual acuity, central macular retinal thickness; intraocular pressure level and complication rate.
Results The observed group was better than the control group with P <0.05.
Conclusion   Lezumab injection combined with phacoemulsification can significantly improve the best corrected visual acuity, central macular retinal thickness; intraocular pressure level, and has excellent safety.

Key words: Cataract; diabetic macular edema; Rizumab; Phacoemulsification; Best corrected vision, Central macular retinal thickness; Intraocular pressure level; Complication rate

参考文献 References

[1] 杨学秋,王存波.雷珠单抗注射液联合白内障超声乳化治疗白内障合并糖尿病性黄斑水肿的临床研究[J].智慧健康,2024,10(18):134-136.

[2] 马诚,刘增业,黑璐宁.白内障合并糖尿病性黄斑水肿不同方式治疗的临床观察[J].临床眼科杂志,2023,31(01):36-39.

[3] 张静静.糖尿病性白内障术中联合药物治疗的价值研究[J].智慧健康,2021,7(10):59-61.

[4] 应令雯,周健.2017ADA糖尿病医学诊疗标准解读[J].中国循环杂志,2017,32(z2):154-161.

[5] 葛华瑞.雷珠单抗注射液联合白内障超声乳化治疗白内障合并糖尿病性黄斑水肿临床研究[J].实用防盲技术,2019, 14(01):19-20+40.

[6] 范丽英,张昊.玻璃体注射抗VEGF药物联合白内障超声乳化术治疗糖尿病性黄斑水肿疗效分析[J].临床和实验医学杂志,2018,17(06):624-626.

[7] 陈海松,武哲明,陈韵,等.同轴微切口白内障超声乳化联合雷珠单抗玻璃体腔注射治疗白内障并糖尿病性黄斑水肿的临床观察[J].广州医药,2018,49(03):29-32.

[8] 张政伟,李松涛.雷珠单抗联合白内障超声乳化术治疗白内障合并糖尿病性黄斑水肿的临床研究[J].临床医药实践,2020,29(02):126-128.

[9] 陈海松,武哲明,陈韵,等.同轴微切口白内障超声乳化联合雷珠单抗玻璃体腔注射治疗白内障并糖尿病性黄斑水肿的临床观察[J].广州医药,2018,49(3):29-32.

[10] 张燕,冯劼,鲁铭,等.康柏西普在糖尿病性白内障患者超声乳化术中的应用[J].眼科新进展,2019,39(11):1052-1055.

引用本文

周翠平, 雷珠单抗注射液联合白内障超声乳化治疗白内障合并糖尿病性黄斑水肿的临床研究[J]. 国际医学与数据杂志, 2024; 8: (3) : 83-86.